Attention-Based Hybrid Deep Learning Models for Classifying COVID-19 Genome Sequences
A. M. Mutawa
No information about this author
AI,
Journal Year:
2025,
Volume and Issue:
6(1), P. 4 - 4
Published: Jan. 2, 2025
Background:
COVID-19
genetic
sequence
research
is
crucial
despite
immunizations
and
pandemic
control.
COVID-19-causing
SARS-CoV-2
must
be
understood
genomically
for
several
reasons.
New
viral
strains
may
resist
vaccines.
Categorizing
sequences
helps
researchers
track
changes
assess
immunization
efficacy.
Classifying
genome
with
other
viruses
to
understand
its
evolution
interactions
illnesses.
Methods:
The
proposed
study
introduces
a
deep
learning-based
genomic
categorization
approach.
Attention-based
hybrid
learning
(DL)
models
categorize
1423
11,388
sequences.
An
unknown
dataset
also
used
the
models.
five
models’
accuracy,
f1-score,
area
under
curve
(AUC),
precision,
Matthews
correlation
coefficient
(MCC),
recall
are
evaluated.
Results:
results
indicate
that
Convolutional
neural
network
(CNN)
Bidirectional
long
short-term
memory
(BLSTM)
attention
layer
(CNN-BLSTM-Att)
achieved
an
accuracy
of
99.99%,
which
outperformed
For
external
validation,
model
shows
99.88%.
It
reveals
DL-based
approaches
can
accurately
classify
high
degree
accuracy.
This
method
might
assist
in
identifying
classifying
virus
clinical
situations.
Immunizations
have
lowered
danger,
but
categorizing
global
health
activities
plan
recurrence
or
future
threats.
Language: Английский
The Impact of Microbiota on Neurological Disorders: Mechanisms and Therapeutic Implications
Giuseppe Merra,
No information about this author
Giada La Placa,
No information about this author
Marcello Covino
No information about this author
et al.
OBM Neurobiology,
Journal Year:
2025,
Volume and Issue:
09(01), P. 1 - 12
Published: Feb. 28, 2025
Interactions
in
the
gut-brain
crosstalk
have
led
to
development
of
an
entirely
new
concept:
"microbiota-gut-brain
axis".
Microbiota
has
gained
considerable
attention
relation
disorders
a
more
neurological
nature,
such
as
neurodevelopmental
and
neuropsychiatric
illnesses
like
autism
spectrum
disorder,
anxiety,
mood
disorders.
This
review
aims
summarize
recent
trends
insights
into
role
consequences
gut
microbiota
brain
health
pediatric
Dysbiosis
may
be
associated
with
increased
risk
diseases
that
lead
different
disruptions
conditions,
including
mental
issues.
During
dysbiosis,
neuropsychological
stress
hormones
usually
affect
oxytocin
GABA
neurons
are
significantly
reduced.
Current
studies
report
major
depression,
cognitive
dysfunction
closely
dysbiosis.
In
last
few
years,
handful
clinical
emerged,
illustrating
potential
for
bidirectional
relationship
interactions
humans.
Perhaps
some
most
crucial
investigations
demonstrating
overlapping
relationships
human
axis
come
from
trials
focusing
on
modulating
noting
significant
correlates.
A
field
is
emerging
gene-editing
technology
could
represent
tool
improve
microbial
characteristics.
approach
particularly
relevant
neurodegenerative
brain-gut
linked
loss
species
and/or
high
pathobiont
load.
Language: Английский
Understanding dysbiosis and resilience in the human gut microbiome: biomarkers, interventions, and challenges
Frontiers in Microbiology,
Journal Year:
2025,
Volume and Issue:
16
Published: March 4, 2025
The
healthy
gut
microbiome
is
important
in
maintaining
health
and
preventing
various
chronic
metabolic
diseases
through
interactions
with
the
host
via
different
gut–organ
axes,
such
as
gut-brain,
gut-liver,
gut-immune,
gut-lung
axes.
human
relatively
stable,
yet
can
be
influenced
by
numerous
factors,
diet,
infections,
diseases,
medications
which
may
disrupt
its
composition
function.
Therefore,
microbial
resilience
suggested
one
of
key
characteristics
a
humans.
However,
our
understanding
definition
indicators
remains
unclear
due
to
insufficient
experimental
data.
Here,
we
review
impact
drivers
including
intrinsic
extrinsic
factors
diet
antibiotics
on
microbiome.
Additionally,
discuss
concept
resilient
highlight
potential
biomarkers
diversity
indices
some
bacterial
taxa
recovery-associated
bacteria,
resistance
genes,
antimicrobial
peptides,
functional
flexibility.
These
facilitate
identification
prediction
microbiomes,
particularly
precision
medicine,
diagnostic
tools
or
machine
learning
approaches
especially
after
that
cause
stable
dysbiosis.
Furthermore,
current
nutrition
intervention
strategies
maximize
resilience,
challenges
investigating
future
directions
this
field
research.
Language: Английский
Progressing microbial genomics: Artificial intelligence and deep learning driven advances in genome analysis and therapeutics
R. Dhaarani,
No information about this author
M. Kiranmai Reddy
No information about this author
Intelligence-Based Medicine,
Journal Year:
2025,
Volume and Issue:
unknown, P. 100251 - 100251
Published: April 1, 2025
Language: Английский
AI-Powered Clinical Trial Design With Translational Bioinformatics
Advances in medical diagnosis, treatment, and care (AMDTC) book series,
Journal Year:
2024,
Volume and Issue:
unknown, P. 57 - 72
Published: June 30, 2024
Clinical
trial
design
is
undergoing
a
revolution
fueled
by
artificial
intelligence
(AI)
and
translational
bioinformatics.
This
chapter
explores
how
AI
techniques
like
machine
learning
deep
are
being
harnessed
to
analyze
vast
datasets
of
biological
clinical
information.
By
integrating
these
insights
with
bioinformatics,
researchers
can
identify
promising
drug
candidates,
select
patients
most
likely
benefit
from
treatment,
more
efficient
targeted
trials.
Real-world
examples
showcase
the
application
in
immuno-oncology
patient
selection,
discovery
for
rare
diseases,
predicting
Alzheimer's
outcomes,
virtual
recruitment
cardiovascular
studies.
While
challenges
data
quality
ethical
considerations
exist,
bioinformatics
hold
immense
promise
accelerating
development,
bringing
life-saving
therapies
faster.
Language: Английский
Harnessing AI for advancing pathogenic microbiology: a bibliometric and topic modeling approach
Frontiers in Microbiology,
Journal Year:
2024,
Volume and Issue:
15
Published: Nov. 15, 2024
Introduction
The
integration
of
artificial
intelligence
(AI)
in
pathogenic
microbiology
has
accelerated
research
and
innovation.
This
study
aims
to
explore
the
evolution
trends
AI
applications
this
domain,
providing
insights
into
how
is
transforming
practice
microbiology.
Methods
We
employed
bibliometric
analysis
topic
modeling
examine
27,420
publications
from
Web
Science
Core
Collection,
covering
period
2010
2024.
These
methods
enabled
us
identify
key
trends,
areas,
geographical
distribution
efforts.
Results
Since
2016,
there
been
an
exponential
increase
AI-related
publications,
with
significant
contributions
China
USA.
Our
identified
eight
major
application
areas:
pathogen
detection,
antibiotic
resistance
prediction,
transmission
modeling,
genomic
analysis,
therapeutic
optimization,
ecological
profiling,
vaccine
development,
data
management
systems.
Notably,
we
found
lexical
overlaps
between
these
especially
drug
suggesting
interconnected
landscape.
Discussion
increasingly
moving
laboratory
clinical
applications,
enhancing
hospital
operations
public
health
strategies.
It
plays
a
vital
role
optimizing
improving
diagnostic
speed,
treatment
efficacy,
disease
control,
particularly
through
advancements
rapid
susceptibility
testing
COVID-19
development.
highlights
current
status,
progress,
challenges
microbiology,
guiding
future
directions,
resource
allocation,
policy-making.
Language: Английский